×
Novo Integrated Sciences EBIT 2012-2024 | NVOS
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
Novo Integrated Sciences ebit from 2012 to 2024. Ebit can be defined as earnings before interest and taxes.
View More
Novo Integrated Sciences EBIT 2012-2024 | NVOS
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
Novo Integrated Sciences ebit from 2012 to 2024. Ebit can be defined as earnings before interest and taxes.
Related Stocks
Company Name
Market
Cap
Fresenius SE (FSNUY)
$21.4B
Quest Diagnostics (DGX)
$17.3B
DaVita (DVA)
$13.8B
Encompass Health (EHC)
$9.2B
Chemed (CHE)
$8.7B
Elanco Animal Health (ELAN)
$7.1B
Option Care Health (OPCH)
$5.3B
RadNet (RDNT)
$4.9B
Amedisys (AMED)
$3.2B
Astrana Health (ASTH)
$2.7B
LifeStance Health (LFST)
$2.6B
Addus HomeCare (ADUS)
$2.4B
U.S Physical Therapy (USPH)
$1.3B
Pennant (PNTG)
$1B
Aveanna Healthcare Holdings (AVAH)
$1B
Atai Life Sciences (ATAI)
$215M
Daxor (DXR)
$46M
ATI Physical Therapy (ATIP)
$26M
MEDIROM Healthcare Technologies (MRM)
$19M
Psychemedics (PMD)
$14M
Ontrak (OTRK)
$10M
IMAC Holdings (BACK)
$2M